Malaria kills millions of people each year and hundreds of millions more suffer chronic illness. Economic development is inhibited and poverty is perpetuated. Tren and Bate argue that action against malaria is over-centralised and narrowly focused, ignoring local conditions and concerns. Health agencies in developing countries and some companies are trying to stem a resurgent tide of malaria. Their work is, however, hampered by pressure from environmentalist groups and donor agencies which still crusade against the use of DDT and which have a partial victory under the POPs (persistent organic pollutants) convention. A continuing anti-DDT campaign would have as its victims people in some of the world's poorest countries.

In Saving Our Streams, Roger Bate explains the history of an unusual and remarkably effective 'environmental' organisation - the Anglers' Conservation Association (ACA). Founded in 1948, the ACA is a voluntary association of angling clubs and individual anglers which brings civil suits against polluters who harm fishing. Dr Bate's original and instructive history explores how the ACA, using the common law, has operated to indemnify its members against the cost of litigation, bringing thousands of actions and being awarded hundreds of injunctions and millions of pounds in damages for plaintiffs. Most cases end in out-of-court settlement which, though efficient, brings little public recognition to the ACA. The ACA has not sought the limelight, unlike other environmental groups, but, argues Dr Bate, it is the most efficient and determined pollution prevention body in Britain. Its success demonstrates the value of private initiatives against polluters.

Roger Bate has spent years on the trail of counterfeit medicines in Asia, Africa, and the Middle East, learning the anatomy of a nebulous, far-reaching black market that has resulted in countless deaths and injuries around the world. Phake: The Deadly World of Falsified and Substandard Medicines is the culmination of Bate's research and travels—both a fascinating firsthand account of the counterfeit drug trade and an incisive policy analysis with important ramifications for decision makers in the U.S. Food and Drug Administration and the international World Health Organization.